NCT04272073

Brief Summary

Cardiovascular disease is responsible for a quarter of all deaths in the UK and risk seems to be higher in cardiac rehabilitation (CR) with lower body weight which may be due to sarcopenci obesity (SO) or low muscle mass with high fat mass. The investigators aim to investigate the effect of a high protein Mediterranean diet and resistance exercise on improving lean mass and reducing risk markers of cardiovascular disease

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 17, 2020

Completed
2.2 years until next milestone

Study Start

First participant enrolled

May 9, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

January 2, 2024

Status Verified

December 1, 2023

Enrollment Period

1.7 years

First QC Date

February 10, 2020

Last Update Submit

December 22, 2023

Conditions

Keywords

sarcopeniaobesitysarcopenic obesitybody compositioncardiac rehabilitationcardiovascular diseasemetabolic syndrome

Outcome Measures

Primary Outcomes (5)

  • Feasability of recruitment

    Recruitment numbers over time course of study

    10 months

  • Follow up rates

    Number of participants that respond to follow up questionnaires

    18 months

  • Acceptability of dietary intervention

    Qualitative data from focus groups

    18 months

  • Acceptability of exercise intervention

    Qualitative data from focus groups

    18 months

  • Adherence to exercise protocol

    Number of exercise sessions actually attended out of number of prescribed sessions

    12 weeks

Secondary Outcomes (22)

  • Change in appendicular skeletal muscle mass (DXA)

    12 weeks

  • Change in muscle mass (DXA)

    12 weeks

  • Change in muscle mass (BIA)

    12 weeks

  • Change in fat mass (BIA)

    12 weeks

  • Change in visceral fat mass (DXA)

    12 weeks

  • +17 more secondary outcomes

Study Arms (2)

Standard Care

ACTIVE COMPARATOR

Participants will perform standard cardiac rehabilitation involving weekly (1-3 days) aerobic-focused exercise sessions in community gyms. Participants will have received guidance on weight management and healthy eating from cardiac rehabilitation staff but will not receive any further dietary support.

Other: Standard Dietary AdviceOther: Standard Cardiac Rehabilitation Exercise

High-Protein mediterranean Diet and Resistance Exercise

EXPERIMENTAL

Participants will be asked to perform resistance exercise. This involves weights or weight machines aimed at building muscle strength. Participants will be required to attend 3 sessions per week and each session is expected to last approximately 45 minutes. Personalised dietary advice: we will ask participants to make changes to their diet to adapt it to a high-protein, Mediterranean-style diet * eating more fruit and vegetables, * reducing commercial pastries, and replacing refined carbohydrate foods (white bread, white rice, white pasta) by wholegrains (wholegrain bread, rice and pasta), * replacing butter and margarine by olive oil as the main culinary fat, * reducing fatty meat and replacing by lean meat, fish, and legumes (peas, beans, lentils), and by high-protein, low fat foods, such as low-fat dairy (participants will be provided with 2 dairy-based protein shakes to consume each day).

Other: High-Protein Mediterranean DietOther: Resistance Exercise

Interventions

As in arm/group descriptions

High-Protein mediterranean Diet and Resistance Exercise

As in arm/group descriptions

High-Protein mediterranean Diet and Resistance Exercise

As in arm/group descriptions

Standard Care

As in arm/group descriptions

Standard Care

Eligibility Criteria

Age30 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent given
  • Referral to cardiac rehabilitation program
  • Ability to attend screening at Liverpool John Moores University
  • Stage 2:
  • Informed consent given
  • Meeting selected criteria to define sarcopenic obesity (dependent on analysis from stage 1)
  • Ability to attend screening at Liverpool John Moores University
  • Cardiac function deemed stable after phase 3 cardiac rehabilitation

You may not qualify if:

  • Inability to perform resistance exercise (determined by primary care team)
  • Renal dysfunction
  • Inability/unwillingness to digest/consume dairy products
  • Admission to CR due to congenital or drug/alcohol-abuse induced cardiac events
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Knowsley Community Cardiovascular Services

Liverpool, United Kingdom

Location

Related Publications (1)

  • McCullough D, Kirwan R, Butler T, Perez de Heredia F, Thijssen D, Lip GYH, Mills J, Davies IG. Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial. Clin Nutr ESPEN. 2021 Oct;45:492-498. doi: 10.1016/j.clnesp.2021.08.001. Epub 2021 Aug 15.

MeSH Terms

Conditions

Cardiovascular DiseasesSarcopeniaObesityMetabolic Syndrome

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Fatima Perez de Heredia Benedicte, PhD

    Liverpool John Moores University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A single-centre, cross-sectional analysis of the prevalence of SO in CR patients followed by a single-centre, 2x2 factorial, open label controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post-graduate researcher

Study Record Dates

First Submitted

February 10, 2020

First Posted

February 17, 2020

Study Start

May 9, 2022

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

January 2, 2024

Record last verified: 2023-12

Locations